On the other hand, the sRANKL/OPG ratio was significantly higher in women with RA before and after 15 months of anti-TNF-α therapy compared to healthy subjects (p < 0.001 for both; Table 4). The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.